NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis

A promising targeted therapy against NY-ESO-1 (CTAG 1B) using genetically modified T-cells in synovial sarcomas was recently demonstrated in a clinical trial at the NCI. To investigate the role of NY-ESO-1 immunohistochemistry in patient selection and gain better insight into the incidence of NY-ESO...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mod Pathol
Main Authors: Lai, Jin-Ping, Robbins, Paul F, Raffeld, Mark, Aung, Phyu Phyu, Tsokos, Maria, Rosenberg, Steven A, Miettinen, Markku M, Lee, Chyi-Chia Richard
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309776/
https://ncbi.nlm.nih.gov/pubmed/22388761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2012.31
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki